Skip to main content
. 2021 Aug 24;107(1):e71–e83. doi: 10.1210/clinem/dgab617

Figure 3.

Figure 3.

Kisspeptin levels throughout pregnancy in women with gestational diabetes mellitus (GDM) compared with control pregnancies and in women with preterm birth (PTB) compared with control pregnancies. A, Scatterplot of medians (IQR) of multiples of gestation-specific median kisspeptin levels in healthy controls (red) (n = 265 women providing 898 samples) and women with GDM (blue) (n = 35 women providing 122 samples); groups were compared by Mann–Whitney U Test. B, Medians (IQR) of plasma kisspeptin levels in healthy controls (red) (n = 265 women providing 898 samples) and women with GDM (blue) (n = 35 women providing 133 samples) over the early and late first trimester, and second and third trimesters. Data were analyzed by Mann–Whitney U Test. C, Scatterplot of medians (IQR) of multiples of gestation-specific median kisspeptin levels in healthy controls (red) (n = 265 women providing 898 samples) and women with PTB (blue) (n = 11 women providing 38 samples); groups were compared by Mann–Whitney U Test. D, Medians (IQR) of plasma kisspeptin levels in healthy controls (red) (n = 265 women providing 898 samples) and women with PTB (blue) (n = 11 women providing 38 samples) over the early and late first trimester, and second and third trimesters. Data were analyzed by Mann–Whitney U Test.